<DOC>
	<DOCNO>NCT01950572</DOCNO>
	<brief_summary>Background : - Malignant mesothelioma malignancy arise mesothelial cell pleura , peritoneum , pericardium , tunica vaginalis . - Mesothelioma account 0.10 % death annually United States . Malignant pleural mesothelioma common , comprise 80 % case annual incidence 2,500 United States . - The median survival diagnosis pleural mesothelioma approximately 12 month . The majority patient present stage III IV disease 85-90 % patient consider unresectable diagnosis . - Peritoneal mesothelioma well prognosis pleural mesothelioma ; nevertheless , patient undergo therapy peritoneal mesothelioma well-studied treatment option due large part rarity disease . Objectives : -To allow sample acquisition use study mesothelioma . Eligibility : - All patient age great equal 2 year malignant mesothelioma - Must able willing provide inform consent 18 ; parent guardian must able willing provide consent patient age 18 Design : - Up 1000 subject enrol . - Patients follow determine course disease record treatment receive mesothelioma . - Patients undergo sample blood , urine , tumor abnormal body fluid tissue banking . - Studies may perform banked material include genetic genomic study , establishment cell culture immunologic study .</brief_summary>
	<brief_title>Tissue Procurement Natural History Study Patients With Malignant Mesothelioma</brief_title>
	<detailed_description>Background : - Malignant mesothelioma malignancy arise mesothelial cell pleura , peritoneum , pericardium , tunica vaginalis . - Mesothelioma account 0.10 % death annually United States . Malignant pleural mesothelioma common , comprise 80 % case annual incidence 2,500 United States . - The median survival diagnosis pleural mesothelioma approximately 12 month . The majority patient present stage III IV disease 85-90 % patient consider unresectable diagnosis . - Peritoneal mesothelioma well prognosis pleural mesothelioma ; nevertheless , patient undergo therapy peritoneal mesothelioma well-studied treatment option due large part rarity disease . - In addition mesothelioma , mesothelin highly express several cancer , include pancreatic , biliary adenocarcinoma , gastric ovarian cancer ; mesothelin also express significantly large proportion thymic carcinoma thymoma . - Mesothelin expression level correlate improved overall survival thymic cancer reduce overall survival patient lung cancer . Objective : -To allow sample acquisition use study mesothelioma mesothelin express cancer . Eligibility : - All patient age great equal 2 year malignant mesothelioma - All patient age great equal 2 18 year thymic carcinoma , pancreatic biliary adenocarcinoma lung , gastric ovarian cancer - Must able willing provide inform consent 18 ; parent guardian must able willing provide consent patient age 18 Design : - Up 1000 subject enrol . - Patients follow determine course disease record treatment receive eligible mesothelin express cancer . - Patients undergo sample blood , urine , tumor abnormal body fluid tissue banking . - Studies may perform banked material include genetic genomic study , establishment cell culture immunologic study .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<criteria>INCLUSION CRITERIA : All patient great equal 2 year age malignant mesothelioma . All patient great equal to18 year age thymic carcinoma , pancreatic biliary adenocarcinoma lung , gastric ovarian cancer . Confirmed pathological diagnosis require Ability willingness subject provide inform consent participation . EXCLUSION CRITERIA : Active symptomatic major organ disorder would increase risk biopsy , include limited ischemic heart disease , recent myocardial infarction , active congestive heart failure , pulmonary dysfunction . Pregnant breast feed woman eligible protocol , undergo tumor biopsy . Active concomitant medical psychological illness may increase risk subject adult patient , inability obtain informed consent , discretion principal investigator .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 11, 2017</verification_date>
	<keyword>Samples</keyword>
	<keyword>Biobank</keyword>
	<keyword>Pleural Mesothelioma</keyword>
	<keyword>Peritoneal Mesothelioma</keyword>
</DOC>